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Background: Haemorrhagic septicaemia (HS) is an acute septicaemic disease of buffalo and cattle caused by
Pasteurella multocida B:2 and E:2. Field outbreaks of HS are known to result in localisation of bacteria in the tonsils
of surviving buffalo, confirming that animals can become carriers and the role of respiratory tract in the
transmission of the disease. This report describes additional sites of localisation of P. multocida B:2 in surviving
buffalo following experimental induction of HS.
Results: Following P. multocida B:2 infection, all calves in group 1 and one calf in group 2 that was allowed to
commingle with infected calves from group 1 were euthanised within 48 h. Pasteurella multocida B:2 was detected
from the nasal and rectal swab samples on days 5 and 6 from the remaining calves in group 2. The first injection of
dexamethasone into the carrier animals resulted in reemergence in samples from the nose, rectum and vagina.
However, subsequent dexamethasone injections failed to re-activate P. multocida B:2. When surviving carrier calves
in group 2 were euthanised at the end of the experiment, P. multocida B:2 was detected in the lungs and various
organs of the respiratory, gastrointestinal and urinary tracts.
Conclusions: Commingling naive buffalo calves with calves acutely infected with P. multocida B:2 resulted in
carriers among surviving buffalo. Pasteurella was found in various organs of the respiratory, gastrointestinal and
urinary tracts, suggesting their role in the pathogenesis of HS.
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tractBackground
Haemorrhagic septicaemia (HS) is an acute, fatal,
septicaemic disease of cattle and buffalo caused by two
specific serotypes of Pasteurella multocida: B:2 (Asian
serotype) and E:2 (African serotype). HS has a wide
distribution, especially in South East Asia and Africa
[1]. On the Malaysian Peninsula, a total of 48 outbreaks of
HS have occurred between 1994 and 2005, resulting in a
total of 921 dead buffalo and 394 dead cattle [2]. A recent
outbreak in India involving free-range cattle and buffalo
resulted in 52 deaths, a mortality rate of 33.76% [3]. In ru-
minants, natural exposure to P. multocida usually results
in rapid disease progression, with typical clinical signs of* Correspondence: mzamri@upm.edu.my
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unless otherwise stated.severe depression, pyrexia, submandibular oedema, dys-
pnoea, recumbency and death. Transmission is typically
by carrier animals [4], which are animals that have sur-
vived a previous outbreak [5]. Previous studies on carriers
were focused on the respiratory tract [5-8] following de-
tection of P. multocida B:2 in the tonsil, nasopharynx and
upper respiratory tract lymph nodes [5,9,10]. Both natural
and experimentally induced stresses aggravate shedding
and transmission of the bacterium [5,11].
One recent study has indicated gastrointestinal tract
involvement in acute HS [12]. However, there have been
no studies on the role of the gastrointestinal and urinary
tracts in carriers and transmission of HS. This paper de-
scribes the experimental development of carrier buffalo
and the role of gastrointestinal and urinary tracts of carrier
buffalo in spreading HS.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Clinical responses
All calves of group 1 were euthanised following develop-
ment of advanced clinical signs; two were euthanised at
24 h post-infection, while the rest were euthanised at
48 h post-infection. Affected calves appeared dull and de-
pressed, recumbent, pyrexic, anorexic and dyspnoeic, with
nasal discharge and diarrhoea.
On days 5, 6 and 7 after being mixed with the calves
from group 1, three calves (2A, 2B and 2C) of group 2
were transiently pyretic, with average body temperatures
of 40.4°C (SEM = 0.15), 40.6°C (SEM = 0.32) and 40.3°C
(SEM = 0.50), respectively (Figure 1). Another calf (2D)
showed progressive pyrexia for more than 48 h and was
euthanised because of severe clinical signs. The surviving
calves in group 2 eventually became carriers. None of
the calves in group 3 showed clinical signs.Gross pathology
In general, all calves of group 1 and one calf (2D) from
group 2 that were euthanised following the development
of severe clinical signs had classic lesions of acute HS,
including severe congestion and haemorrhage of mucosal
surfaces, subcutaneous tissues and respiratory, gastrointes-
tinal and urinary tracts. Fibrin was deposited on the se-
rosal surfaces of all thoracic and abdominal organs.
The surviving calves of group 2 had multifocal pul-
monary congestion and pneumonia. Fibrin was deposited
on the omentum, mesentery, peritoneum and serosal
surfaces of the gastrointestinal tract. However, the mu-
cosal surfaces of the gastrointestinal tract appeared nor-
mal apart from the rectum, which had mild multifocal
haemorrhages.Figure 1 Time line and mean rectal temperature: comparison betwee
significant difference of p < 0.05 compared with the negative control group
animals in group 1 euthanised. c: Day 5 and 6: positive isolation made from
Day 7: 2D euthanised. d: Day 15: positive P. multocida B:2 from rectal swab
carriers and rectal swab of 2B. f: Day 17: positive P. multocida B:2 from nasaIsolation and identification of P. multocida B:2
Pasteurella multocida B:2 was successfully isolated from
organ samples of all calves that were euthanised because
of acute HS.
Pasteurella multocida B:2 was cultured from nasal and
rectal swabs collected on days 5 and 6 from the surviving
buffalo calves (2A, 2B, 2C) of group 2 on post-exposure
days 5–7 and 15–17 (5–7 days after the administration of
the first course of dexamethasone). Pasteurella multocida
B:2 was also isolated from vaginal swabs of these calves
on post-exposure days 15–17. Isolation was unsuccess-
ful between days 7 and 14 and following the second and
third courses of dexamethasone (Figure 1). At the end
of the 43-day experiment, P. multocida B:2 was detecti-
ble via polymerase chain reaction (PCR) in the tonsils,
lung, reticulum, ileum and ureter of calves 2A, 2B and
2C (Table 1).
Immunoperoxidase examination
The respiratory, gastrointestinal and urinary tracts of all
surviving group 2 calves had mild to moderate P. multo-
cida B:2 immunoreactivity. Within the respiratory tract,
immunoreactivity was noted in the nasal mucosa, tonsil,
epiglottis, trachea and the lungs. In the nasal mucosa, the
cells of nasal glands showed intracytoplasmic immunore-
activity (Figure 2A) while the tonsillar epithelium and ton-
sillar crypts had immunoreactivity amidst cellular debris
(Figure 2B). Rare immunopositive bipolar rods were de-
tected on the tonsillar epithelium and crypts.
Similar immunoreactivity was detected in the cells of
serous glands, the epithelial cells of the epiglottis and on
the epithelium of the trachea (Figure 2C). In the lungs,
positive immunoreaction was observed on the surface
of pneumocytes. Intracytoplasmic immunoreaction wasn carrier animals and negative control animals. **indicates a
. a: Day 1: inoculation of P. multocida B:2 to group 1. b: Day 2: all
nasal and rectal swabs from carrier animals in group 2 (2A, 2B, 2C).
of 2A. e: Day 16: positive P. multocida B:2 from nasal swabs of all
l swab of 2A as well as rectal and vaginal swabs of all carriers.
Table 1 Pasteurella multocida B:2 isolation, DNA
detection and localisation in all samples from calves 2A,
2B and 2C
Tract Organ P. multocidaB:2
DNA (+/total)
Localisation
Respiratory Nasal 0/3 Serous glands.




Epiglottis 0/3 Epithelium, serous
glands.
Trachea 0/3 Epithelial surface.






Gastrointestinal Liver 0/3 (negative)

















Urinary Kidney 0/3 (negative)
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lar macrophages (Figure 2D). Positive immunoreactivity
was also detected in bronchiolar exudates that were mixed
with desquamated bronchiolar epithelial cells.
Within the gastrointestinal tract, all organs had immu-
noreaction except for liver and mesenteric lymph nodes.
The rumen, reticulum and omasum had positive immu-
noreactivity beneath the keratin layer (Figure 3A), while
the abomasum was immunoreactive at the tips of the
mucosal surface (Figure 3B). Similar positive reactions
were found at the tips of the mucosal surfaces in allsections of small and large intestines and within rare
infiltrating macrophages.
There was no immunoreactivity in any kidney samples.
However, the ureter showed mild intracytoplasmic immu-
noreaction within the epithelial cells. Few immunopositive
bipolar rods were detected in ureteral lumina (Figure 4A).
Similar mild immunoreactions were observed in sections
from the urinary bladder, particularly in the urothelial cells
(Figure 4B).
There was no immunoreactivity in any tissues from
calves in group 3 (Figure 5).
Discussion
In this experiment, carriers were detected among surviving
buffalo that were allowed to comingle with the infected
buffalo, simulating field outbreaks of HS. In addition to
carriers, commingling buffalo can die of HS, as observed
in calf 2D. Susceptible animals have been shown to rapidly
succumb to HS following exposure to a high dose of
P. multocida B:2, because of either a high growth rate
within the host or the presence of other virulence factors
that enable the agent to overcome the host’s defense
mechanisms. Furthermore, poor development of specific
and non-specific immunity of the host contributes to
the development of acute HS [13]. The involvement and
interactions between these factors are not fully under-
stood [5]. If the host’s defense mechanisms prevail
against the agent, the animals become carriers, as ob-
served among the surviving buffalo calves of group 2
[11]. However, mixing naive animals with acutely in-
fected animals to create carriers has the limitation of
not being able to control the infection dose [5]. If the
naive animals survive and become carriers, there may
be individual differences in clinical signs, tissue tropism
and disease course. It does have the advantage of more
closely replicating field disease exposure.
Administration of courses of dexamethasone to car-
riers simulated stress and immunosuppression [12,14],
leading to shedding and detection of P. multocida B:2 in
the respiratory, gastrointestinal and urinary tracts. This
confirms the involvement of the gastrointestinal and
urinary tracts as potential transmission routes for HS by
carriers following stress. This suggests a mechanism for
outbreaks of HS that occurred during stressful monsoon
seasons [4].
Immunoperoxidase staining localised P. multocida B:2
within the respiratory, gastrointestinal and urinary tracts of
carriers. In HS, there are two types of carriers: active and la-
tent. Active carriers actively shed bacteria and the agent
may be cultured or detected during a post-mortem examin-
ation. Latent carriers do not shed bacteria but the agent
can be cultured or demonstrated at low concentrations
during post-mortem [4,5,15,16]. In this study, P. multocida
B:2 was detected in the respiratory, gastrointestinal and
Figure 2 Immunolocalisation of P. multocida B:2 in the respiratory tracts of carriers. A. Serous glands in the nasal passage (bar = 100 μm).
B. Tonsillar crypts mixed with cellular debris (bar = 100 μm). C. Ciliated tracheal epithelium (bar = 50 μm). D. Intracytoplasmic immunoreactivity in
alveolar macrophages and on the surface of the alveolar sac (bar = 50 μm).
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gests these animals were latent carriers [17]. At the time
of euthanasia, the agent could no longer be isolated, unlike
previous studies [5,7,8] and was associated with mild im-
munoreactivity on the mucosal surfaces of the respiratory,
gastrointestinal and urinary tracts. Demonstration of im-
munoreactive bipolar rods is consistent with infiltration of
the tonsil, as suggested by previous studies [5,9,10,14,18].
However, this study localised P. multocida B:2 to the
gastrointestinal and urinary tracts of carrier buffalo for the
first time. While the tonsil may be the most important
tissue reservoir in carriers, it is not the only organ of
concern.
Conclusions
Successful isolation of P. multocida B:2 from nasal, rectal
and vaginal swabs suggests that buffalo that survive experi-
mental outbreaks of HS become carriers. The organismFigure 3 Immunolocalisation of P. multocida B:2 in the gastrointestin
B. Abomasal mucosa (bar = 100 μm).is not only located in the respiratory tract as previously
believed, but is also detectable in the gastrointestinal




Twelve eight-month-old, clinically healthy, buffalo calves
from a farm with no history of HS or vaccination against
P. multocida were selected for the study. Calves were
acclimatised for a period of 5 days and treated with an-
thelmintics. Nasal swabs were collected daily to ensure
calves were free from P. multocida by culture and PCR
[19]. Calves were fed cut grass supplemented with
400 g/calf/day of palm kernel-based pellets. Drinking
water was available ad libitum. Access to veterinary care
was available at all times and the well-being of the
calves was assessed regularly.al tract of carriers. A. Keratinised mucosa of reticulum (bar = 50 μm).
Figure 4 Immunolocalisation of P. multocida B:2 in the urinary tract of carriers. A. Ureteral epithelium. Note the presence of two
immunopositive bipolar rods suggestive of P. multocida B:2 (bar = 10 μm). B. Urinary bladder wall (bar = 50 μm).
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Stock cultures of P. multocida B:2 isolated from a previ-
ous outbreak of HS were used to prepare the inoculum.
Bacteria were cultured onto blood agar plates and incu-
bated at 37°C for 24 h. Four colonies were inoculated
into brain-heart infusion broth and incubated at 37°C
with shaking at 150 revolution per minute (rpm) for
18 h. Bacteria were quantified via serial dilution, and an
infective inoculum containing 1.0 × 105 colony forming
units (cfu)/mL was prepared [20].
Experimental design
All experiments were approved by the Animal Care and
Use Committee of Universiti Putra Malaysia (approval
number 12R148).
Calves were divided into three equal groups. Group 1
served as the infected group, group 2 (consisting of calves
2A, 2B, 2C and 2D) as the commingling group and group
3 as the negative control group. All calves of group 1 wereFigure 5 Negative control samples. A. Trachea (bar = 100 μm). B. Lungschallenged subcutaneously at the shoulder with 5 mL of
inoculum containing 1.0 × 105 cfu/mL of P. multocida
B:2 [21]. Calves of group 2 were not infected but were
kept together and were allowed to commingle with the
infected calves of group 1 [22]. Calves of group 3 were
inoculated subcutaneously at the shoulder region with
sterile phosphate-buffered saline and housed separately.
Following inoculation, all calves were observed for clinical
signs of HS and rectal temperatures were checked daily.
Calves with advanced clinical signs were euthanised
according to the guideline of the Ethics Committee,
Universiti Putra Malaysia.
Deep nasal, rectal and vaginal swabs were collected
daily from all animals, throughout the 43-day study
period using sterile cotton swabs. Deep nasal swabs were
obtained by cleaning the external nares with 70% alcohol,
inserting the swabs 15 cm into the nostrils, and swabbing
the nasal and nasopharyngeal mucosa by rotating the
swabs several times. The rectal and vaginal swabs were(bar = 100 μm). C. Rectum (bar = 100 μm). D. Ureter (bar = 100 μm).
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70% alcohol, inserting the swabs 7 cm into the rectum
or vagina, and swabbing the vaginal and rectal mucosa
by rotating the swabs several times. All swab samples
were immediately transported to the laboratory in Cary
Blaire medium.
Once a week had passed with no positive cultures, calves
were injected intramuscularly with dexamethasone (Dexa-
son; Troy Laboratories) for 3 consecutive days at the rate
of 1 mg/kg to induce immunosuppression [12]. After the
first set of injections, two additional series of dexametha-
sone injections followed at 7-day intervals.
After the final dexamethasone injection, all surviving
calves in groups 2 and 3 were euthanised. Samples of
nasal passage, tonsil, epiglottis, trachea, all eight lung
lobes, liver, rumen, reticulum, omasum, abomasum, duo-
denum, jejunum, ileum, mesenteric lymph nodes, caecum,
colon, rectum, kidney, ureter and urinary bladder were
collected from all euthanised animals in 10% neutral buff-
ered formalin.
Tissue samples from group 1 were subjected to culture
and identification of P. multocida B:2. Tissue samples
from the surviving buffalo of group 2 and negative control
of group 3 were subjected to culture and identification of
P. multocida B:2, histopathologic and immunohistochemi-
cal examination.
Isolation and identification of P. multocidaB:2
All nasal, rectal and vaginal swabs were cultured on blood
agar plates incubated at 37°C for 18 h. Identification of
P. multocida B:2 was based on morphological criteria
[23] and PCR [19]. Tissue samples were homogenised and
diluted before deoxyribonucleic acid (DNA) extraction
(NucleoSpin® Tissue; Macherey-Nagel, Düren, Germany).
Purified DNA was subjected to detection by PCR [19].
Localisation of P. multocida B:2
Tissue samples were fixed in 10% buffered formalin for
at least 24 h before being trimmed, embedded in paraffin
and sectioned at 3 μm. Sections were then subjected to
immunoperoxidase and methylene blue stainings. Sections
were dewaxed by incubation at 60°C for 15 min and
immersion into xylene. Rehydration was via successive
immersion in absolute alcohol, 90% alcohol, 70% alcohol
and 50% alcohol. Sections were then exposed to citrate
buffer using a carousel microwave at 50 W for 15 min
and then Dako REAL™ Peroxidase Blocking Solution at
room temperature for 30 min. Samples were incubated
with primary rabbit hyperimmuneserum (1:200) against
P. multocida B:2 at 37°C for 1 h, and then incubated
with 1:1000 diluted peroxidase conjugated antiserum
(polyclonal goat anti-rabbit immunoglobulin G (IgG);
Dako) at 37°C for 30 min. Finally, sections were incu-
bated with 3,3′-diaminbenzidine (DAB) (Dako LiquidDAB+ SubstrateChromogen System) at room temperature
for 2 min, followed by washing in distilled water and
counterstaining with methylene blue. Finally, all sections
were examined under a light microscope.
Adjacent sections were dewaxed and stained with
methylene blue for 30 s before being examined under
light microscope to detect bipolar P. multocida B:2.
Statistical analysis
The Student’s t test was used to compare rectal tempera-
tures between the carriers and control calves.
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